Overcoming Hurdles to Development of a Vaccine against Pneumocystis jirovecii
- PMID: 28115507
- PMCID: PMC5364313
- DOI: 10.1128/IAI.00035-17
Overcoming Hurdles to Development of a Vaccine against Pneumocystis jirovecii
Abstract
Development of Pneumocystis pneumonia (PCP) is a common problem among immunosuppressed individuals. There are windows of opportunity in which vaccination would be beneficial, but to date, no vaccines have made it to clinical trials. Significant hurdles to vaccine development include host range specificity, making it difficult to translate from animal models to humans. Discovery of cross-reactive epitopes is critical to moving vaccine candidates from preclinical animal studies to clinical trials.
Keywords: Pneumocystis carinii; vaccines.
Copyright © 2017 American Society for Microbiology.
Similar articles
-
Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.Infect Immun. 2017 Mar 23;85(4):e00850-16. doi: 10.1128/IAI.00850-16. Print 2017 Apr. Infect Immun. 2017. PMID: 28031260 Free PMC article.
-
Synthetic p55 tandem DNA vaccine against Pneumocystis carinii in rats.Microbiol Immunol. 2016 Jun;60(6):397-406. doi: 10.1111/1348-0421.12386. Microbiol Immunol. 2016. PMID: 27185490
-
Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats.Can J Microbiol. 2011 May;57(5):375-81. doi: 10.1139/w11-023. Epub 2011 May 4. Can J Microbiol. 2011. PMID: 21529125
-
Nosocomial Pneumocystis jirovecii infections.Parasite. 2008 Sep;15(3):359-65. doi: 10.1051/parasite/2008153359. Parasite. 2008. PMID: 18814707 Review.
-
[Pneumocystis pneumonia in patients with immunosuppression other than HIV infection].Rev Med Suisse. 2008 Nov 19;4(180):2525-6, 2528-30. Rev Med Suisse. 2008. PMID: 19127897 Review. French.
References
-
- Tesini BL, Wright TW, Malone JE, Haidaris CG, Harber M, Sant AJ, Nayak JL, Gigliotti F. 2017. Immunization with Pneumocystis cross-reactive antigen 1 (Pca1) protects mice against Pneumocystis pneumonia and generates antibody to Pneumocystis jirovecii. Infect Immun 85:e00850-16. doi:10.1128/IAI.00850-16. - DOI - PMC - PubMed
-
- Gajdusek DC. 1957. Pneumocystis carinii; etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics 19:543–565. - PubMed
-
- Anderson KC, Soiffer R, DeLage R, Takvorian T, Freedman AS, Rabinowe SL, Nadler LM, Dear K, Heflin L, Mauch P. 1990. T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications. Blood 76:235–244. - PubMed
-
- Siegel SE, Nesbit ME, Baehner R, Sather H, Hammond GD. 1980. Pneumonia during therapy for childhood acute lymphoblastic leukemia. Am J Dis Child 134:28–34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources